Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Neocore is a neurotechnology company that develops EEG-integrated earbuds designed to dynamically adapt digital content to a user's real-time brain state. The company's flagship product, OneSpark, captures brain signals via the ear to detect attention, engagement, and cognitive fatigue. Utilizing its proprietary neuroadaptive AI platform, AYA (Adaptive Yield Algorithm), and the companion app MyBrain, Neocore reshapes the pacing, structure, and modality of content to match the user's moment-to-moment cognitive state. This technology is particularly targeted at individuals with ADHD and attention variability, offering a personalized cognitive environment that reduces fatigue and boosts engagement.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Neocore research fund.